Please use this identifier to cite or link to this item:
http://hdl.handle.net/1880/50111| Title: | Survivin as a Preferential Target for Cancer Therapy |
| Authors: | Mobahat, Mahsa Narendran, Aru Riabowol, Karl |
| Issue Date: | 13-Feb-2014 |
| Publisher: | Multidisciplinary Digital Publishing Institute |
| Citation: | Int. J. Mol. Sci. 2014, 15, 2494-2516; doi:10.3390/ijms15022494 |
| Description: | Article deposited according to MDPI’s policy for International Journal of Molecular Sciences: http://www.mdpi.com/authors June 20, 2014 |
| URI: | http://hdl.handle.net/1880/50111 |
| Appears in Collections: | Riabowol, Karl T. Mobahat, Mahsa Narendran, Aru |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2014_InternationalJournalofMolecularSciences_Riabowol.pdf | 447.75 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License
